Justia Products Liability Opinion Summaries

Seven years after Plyler installed a Whirlpool microwave oven and eight hours after using that oven, a houseguest woke him because of a fire in the microwave. Firefighters extinguished the fire. Plyler claims that he injured his elbow and knee while he ran into and out of his house and that he experienced post-traumatic stress disorder. At trial on negligent recall and strict liability claims, a fire department investigator could not identify a specific cause of the fire. Plyler blamed the fire on a product defect that had led Whirlpool to recall microwaves in 2001. Whirlpool’s Director of Global Product Safety testified that the ovens posed a fire hazard only if they contained splattered food. uncleaned for an extended time, and were running at the time of the fire. After Whirlpool discovered that 1.8 million microwaves contained the defect, it issued a recall through the Consumer Product Safety Commission, mailed notices to owners who had submitted a product registration card, and released news announcements. Although the average recall leads to repair or replacement of 10 to 15 percent of affected units, Whirlpool repaired 75 percent of the recalled microwave. Plyler stated that he kept his microwave clean; that he never received notice; that he paid for it with a credit card; and that Whirlpool should have been able to contact him. The jury found in favor of Whirlpool. The Seventh Circuit affirmed, rejecting challenges to rulings that limited Plyler’s testimony to his observations and that allowed questions about the relationship between the fire and his divorce.View "Plyler v. Whirlpool Corp." on Justia Law

In 1995 the FDA approved Fosamax® to treat or prevent osteoporosis and Paget’s Disease. Teva developed alendronate sodium, a generic form of the branded drug, and obtained FDA approval on its abbreviated new drug application in 2008. Other generic manufacturers subsequently obtained approval for formulations. The drugs act by inhibiting bone resorption or absorption and suppressing bone turnover; they also inhibit primary mineralization, which is involved in the formation of new bone. Meanwhile, secondary mineralization of existing bone continues, which increases the bone’s mineral content and results in higher bone mineral density. According to the plaintiffs, higher bone mineral density does not necessarily correspond with reduction of fracture risk but can make bone highly mineralized, homogenous, brittle, and more susceptible to fracture. According to some studies, the effects of alendronate sodium linger, with one study reporting that bone turnover may be inhibited by 50% five years after discontinuing treatment. The district court granted judgment on the pleadings in favor of the generic manufacturer defendants finding that state-law strict liability claims were pre-empted by federal law. The Seventh Circuit affirmed. Manufacturers have no control over the design or labeling of generic drugs; the plaintiffs failed to identify anything the generic defendants could do to reconcile their conflicting duties under state and federal law. View "In re: Fosmax (Alendronate Sodium)" on Justia Law

In the late 1990s, people who had taken the prescription diet-drug combination Fen-Phen began suing Wyeth, claiming that the drugs caused valvular heart disease. A 2000 settlement included creation of the Fen-Phen Settlement Trust to compensate class members who had sustained heart damage. Claims required medical evidence. Attorneys who represented certain claimants retained Tai, a board-certified Level 2-qualified cardiologist, to read tests and prepare reports. Tai read 12,000 tests and asserted that he was owed $2 million dollars for his services. Tai later acknowledged that in about 10% of the cases, he dictated reports consistent with the technicians’ reports despite knowing that the measurements were wrong, and that he had his technician and office manager review about 1,000 of the tests because he did not have enough time to do the work. A review of the forms Tai submitted found that, in a substantial number of cases, the measurements were clearly incorrect and were actually inconsistent with a human adult heart. Tai was convicted of mail and wire fraud, 18 U.S.C. 1341 and 1343, was sentenced to 72 months’ imprisonment, and was ordered to pay restitution of $4,579,663 and a fine of $15,000. The Third Circuit rejected arguments that the court erred by implicitly shifting the burden of proof in its “willful blindness” jury instruction and applying upward adjustments under the advisory Sentencing Guidelines for abuse of a position of trust and use of a special skill, but remanded for factual findings concerning whether Tai supervised a criminally culpable subordinate, as required for an aggravated role enhancement. View "United States v. Tai" on Justia Law

Robert Reeves, an employee of Illinois Central Railroad, sued Mississippi Valley Silica, Inc. for lung injuries that allegedly were caused by his inhalation of silica while employed with Illinois Central. The case was dismissed without prejudice in 2006, and this suit was filed against thirty-two named defendants in 2007. Robert Reeves died in 2010, before the litigation was concluded, and the case then was pursued by his wrongful death beneficiaries. After trial in May 2012 against the sole remaining defendant, Valley, the jury found economic damages in the amount of $149,464.40 and noneconomic damages of $1.5 million, with Valley 15% at fault. The jury also awarded punitive damages of $50,000, and the trial court awarded attorney fees of $257,701.50. Although Valley was found only 15% at fault, the trial court determined that the law in place in 2002, when the original complaint was filed, should have applied. Accordingly, the statutory caps on punitive and noneconomic damages enacted in 2004 were inapplicable and Valley was jointly and severally liable for 50% of the judgment. Ultimately, the court determined that Valley owed the Reeves beneficiaries $824,732.20, plus $50,000 in punitive damages, and $257,701.50 in attorney fees, for a total of $1,132,433.70. Valley appealed. Upon review of the matter, the Supreme Court concluded that plaintiff failed to present sufficient evidence to identify Valley’s sand as the proximate cause of Robert Reeves’s injuries as a matter of law. Therefore, the Court reversed the trial court and rendered judgment in favor of Mississippi Valley Silica. View "Mississippi Valley Silica Company, Inc. v. Reeves" on Justia Law

In this product liability action, plaintiff appealed a judgment for defendants after a jury trial. The Court of Appeals affirmed without considering the merits of nine of plaintiff's ten assignments of instructional and evidentiary error. Plaintiff contended on appeal that, in so holding, the Court of Appeals misconstrued the standard for reversal in ORS 19.415(2) as it applied to claims of instructional and evidentiary error like those that the court declined to consider. Upon review, the Supreme Court found that the appellate court erred in its reasoning for not considering all of plaintiff's arguments. Accordingly, the Court reversed and remanded this case to the Court of Appeals to address plaintiff's assignments of error. View "Purdy v. Deere & Company" on Justia Law

Company Doe filed suit to enjoin the Commission from publishing in its online, publicly accessible database a "report of harm" that attributed the death of an infant to a product manufactured and sold by Company Doe. Consumer Groups filed a post-judgment motion to intervene for the purpose of appealing the district court's sealing order as well as its decision to allow Company Doe to proceed under a pseudonym. The court held that Consumer Groups' notice of appeal deprived the district court of jurisdiction to entertain Consumer Groups' motion to intervene, and, therefore, the court vacated the district court's order denying intervention; Consumer Groups were able to seek appellate review of the district court's orders because they met the requirements for nonparty appellate standing and have independent Article III standing to challenge the orders; and, on the merits, the district court's sealing order violated the public's right of access under the First Amendment and the district court abused its discretion in allowing Company Doe to litigate pseudonymously. Accordingly, the court vacated in part, reversed in part, and remanded with instructions. View "Company Doe v. Public Citizen" on Justia Law

This case arose when 702 plaintiffs from 26 different states and the Commonwealth of Puerto Rico filed twelve nearly identical product liability actions against the defendants in the District Court of Pottawatomie County, Oklahoma. The defendants are manufacturers of transvaginal mesh medical devices. The plaintiffs were women who were implanted with the devices and their husbands, who assert loss-of-consortium claims. None of the individual actions contained 100 or more plaintiffs. Each of the actions included at least one New Jersey resident plaintiff. Each complaint specifically disclaimed federal question and federal diversity jurisdiction, and included provisions that admitted the claims had been joined for the purpose of pretrial discovery and proceedings but disclaimed joinder for trial purposes. All twelve actions were assigned to the same state court judge. The defendants, corporate residents of New Jersey, removed the actions to the United States District Court for the Western District of Oklahoma, relying on both diversity jurisdiction and Class Action Fairness Act (CAFA) removal jurisdiction, arguing that complete diversity existed between the parties because in each action, the New Jersey citizen plaintiff had been fraudulently joined and should therefore be disregarded for diversity purposes. They further contended that jurisdiction was available under CAFA’s "mass action" provision because, by filing all of the suits in the same court before the same judge, plaintiffs had proposed a joint trial of claims involving more than 100 plaintiffs. Plaintiffs moved to remand eleven of the actions, involving 650 plaintiffs, to state court. The district court granted their motion. It declined to adopt the procedural misjoinder doctrine raised by the defendants, and concluded that plaintiffs had not in fact proposed a joint trial of their claims. Defendants appealed that order to the Tenth Circuit Court of Appeals. Finding no reversible error, the Tenth Circuit affirmed the remand of those cases to state court. View "Teague, et al v. Johnson & Johnson, et al" on Justia Law

Plaintiff filed suit against Novartis, manufacturer of Zometa, alleging products liability, negligent manufacture, negligent failure to warn, breach of express and implied warranty, and loss of consortium. On appeal, plaintiff contended that the district court erred by excluding the causation testimony offered by her expert when it found the testimony to be irrelevant and unreliable. The court concluded that the expert's testimony was relevant because it indicated that plaintiff's bisphosphonate use was a substantial factor in her development of bisphosphonate-related osteonecrosis of the jaw. The court also concluded that the expert's testimony was reliable where he used a differential diagnosis grounded in significant clinical experience and examination of medical records and literature. Accordingly, the court concluded that the expert's testimony created a genuine issue of material fact regarding the specific causal link between plaintiff's bisphosphonates treatment and her development of osteonecrosis of the jaw. The court reversed the district court's summary judgment in favor of Novartis and remanded. View "Messick v. Novartis Pharmaceuticals Corp." on Justia Law

Plaintiff filed suit under 42 U.S.C. 1983 against the city and several police officers after her son was shot in the chest with an electronic control device (ECD). After the case settled, plaintiff filed suit against TASER for products liability and negligence. The court concluded that plaintiff's failure to warn claim failed as a matter of law because she did not establish on the record that an additional warning would have changed the behavior of the officers involved; the district court did not abuse its discretion in excluding plaintiff's expert's testimony on the issue of whether a different or additional warning would have altered the officer's actions under the existing circumstances; even if the court were to conclude that there was a legitimate jury question as to whether the officer had been made aware of the specific risk of cardiac danger when the ECD was fired directly at the subject's chest, such a conclusion would be rebuttable by undisputed evidence in the record that he had not been instructed on available warnings and did not heed the limited training he had received; there was no genuine dispute on the record that the officer would not have read any additional warning TASER may have added as to the cardiac danger of the ECD in any of its product warnings or bulletins, or in any training materials prepared after January 1, 2005; even if an adequate warning had appeared, the officer would not have heeded it; and therefore, TASER was entitled to summary judgment on plaintiff's negligence and failure to warn claims where she failed to establish that an additional warning would have altered the behavior of the officer. The court also concluded that plaintiff failed to present evidence that the ECD device used by the officer was unreasonably dangerous as designed. Plaintiff's design defect claim failed as a matter of law where plaintiff failed to demonstrate any "specific design choices" that rendered the model unreasonably dangerous. Accordingly, the court affirmed the district court's judgment and dismissed plaintiff's remaining claims as moot. View "Bachtel v. TASER Int'l, Inc." on Justia Law

Sixteen-year-old Jessica Bowers sustained severe injuries when she was dragged into the rotating driveline of a tractor-driven post hole digger that was operated by her stepfather, who had borrowed the digger from Peter Smith. Smith had previously removed a plastic safety shield from the machine after years of use had left the shield damaged beyond repair. Plaintiff sued the digger’s seller, distributor, manufacturer, component maker, and others, asserting claims sounding in negligence and strict products liability. Defendants argued that they were entitled to summary judgment based on the substantial modification defense articulated in Robinson v. Reed-Prentice Division of Package Machinery Company because Smith made post-sale modifications to the digger that rendered the digger defective and proximately caused Plaintiff’s injuries. Supreme Court denied summary judgment with regard to the design defect claims. The case proceeded to trial, and the jury returned a verdict in favor of Plaintiff. The Appellate Division affirmed. The Court of Appeals affirmed, holding that Plaintiff raised triable issues of fact regarding the defective design of the safety shield that were sufficient to defeat summary judgment based on substantial modification. View "Hoover v. New Holland N. Am., Inc." on Justia Law